DEFA14A: Zomedica Urges Shareholder Participation Ahead of Virtual Annual Meeting

Zomedica Corp. has issued a reminder to its shareholders to submit their proxies by June 8, 2025, for the upcoming virtual Annual Shareholder Meeting on June 10, 2025.

Summary

• Zomedica Corp. sent a message to its shareholders via Say Technologies, LLC on May 29, 2025, regarding its 2025 Annual Meeting of Shareholders.
• The Annual Shareholder Meeting will be held virtually on June 10, 2025, at 11:00 a.m. EDT.
• Shareholders are urged to submit their proxy votes by June 8, 2025, at 11:59 p.m. EDT to ensure their vote is counted.
• The company highlighted that it released its Q1 financials in Form 10-Q and an earnings summary in Form 8-K on May 15, 2025, for shareholder review.

Sentiment

Score: 7

Explanation: The sentiment is positive, focusing on shareholder engagement and the importance of their vote, without presenting any negative news or challenges. It's a standard, encouraging communication.

Positives

• The company is actively engaging with retail investors through platforms like Say Technologies, LLC, emphasizing their importance and encouraging participation.
• Management expresses a positive outlook on shareholder involvement, stating 'Your involvement truly makes a difference' and 'we're stronger with you on board'.

Future Outlook

The document primarily focuses on the procedural aspects of the upcoming Annual Shareholder Meeting and encourages shareholder participation to 'shape the future together,' implying a forward-looking collaborative approach without specific financial guidance.

Management Comments

• "If you own shares—even just one—you have a say in where we're headed."
• "Our Annual Shareholder Meeting is happening virtually on June 10 at 11:00 a.m. EDT, and we'd love for you to be part of it."
• "To make sure your vote is counted, please submit your proxy by June 8 at 11:59 p.m. EDT."
• "We know retail investors like you care about how the company performs and grows. That's why we've shared updates to help you stay informed."
• "Now we're asking for your support. Review the materials, make your voice heard, and vote. Your involvement truly makes a difference."
• "Thanks for being on this journey with us—we're stronger with you on board." Larry Heaton, Chief Executive Officer, Zomedica

Industry Context

This announcement is a standard procedural communication common across publicly traded companies, emphasizing shareholder engagement and corporate governance. It does not provide specific industry-related trends or competitive insights beyond the general practice of holding annual shareholder meetings and providing financial updates.

Corporate Governance

Stakeholder Impact

• **Shareholders**: Directly impacted by the call to action to vote on company matters, influencing future direction. The company emphasizes the value of retail investor input.
• **Management**: Seeks shareholder support for proposed resolutions and continues to engage with the investor base.

Next Steps

• Shareholders to review Q1 financials (Form 10-Q) and earnings summary (Form 8-K).
• Shareholders to submit their proxy votes by June 8, 2025, 11:59 p.m. EDT.
• Virtual Annual Shareholder Meeting to be held on June 10, 2025, at 11:00 a.m. EDT.

Key Dates

Keywords

Zomedica, Shareholder Meeting, Proxy Vote, Corporate Governance, SEC Filing, DEFA14A, Annual Meeting, Investor Relations